Pharmaceutical manufacturers face growing cyber risks as production environments become increasingly interconnected. While regulatory frameworks such as GMP, FDA requirements, and NIS2 strengthen governance, compliance alone does not provide continuous visibility into evolving threats across IT, OT, and production-critical systems.
This whitepaper explores the visibility gap that can leave organizations exposed despite meeting regulatory requirements and examines how cybersecurity is becoming a critical component of operational resilience.
Download the whitepaper to explore:
• Why compliance does not always equate to security
• How IT/OT convergence is expanding the pharmaceutical attack surface
• The operational impact of cyber incidents on production and regulatory compliance
• Why continuous visibility is essential for managing cyber risk
• Strategies for strengthening resilience in the NIS2 era
Complete the form to access the whitepaper.
